The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels

Abstract

The ubiquitously expressed protein glycogen synthase kinase-3 (GSK3) is constitutively active, however its activity is markedly diminished following phosphorylation of Ser21 of GSK3α and Ser9 of GSK3β. Although several kinases are known to phosphorylate Ser21/9 of GSK3, for example Akt, relatively much less is known about the mechanisms that cause the dephosphorylation of GSK3 at Ser21/9. In the present study KCl-induced plasma membrane depolarization of SH-SY5Y cells, which increases intracellular calcium concentrations caused a transient decrease in the phosphorylation of Akt at Thr308 and Ser473, and GSK3 at Ser21/9. Overexpression of the selective protein phosphatase-1 inhibitor protein, inhibitor-2, increased basal GSK3 phosphorylation at Ser21/9 and significantly blocked the KCl-induced dephosphorylation of GSK3β, but not GSK3α. The phosphorylation of Akt was not affected by the overexpression of inhibitor-2. GSK3 activity is known to affect sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) levels. Overexpression of inhibitor-2 or treatment of cells with the GSK3 inhibitors lithium and SB216763 increased the levels of SERCA2. These results indicate that the protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation induced by KCl and that GSK3 activity regulates SERCA2 levels. KeywordsAkt; glycogen synthase kinase-3; inhibitor-2; protein phosphatase-1; sarcoplasmic/endoplasmic reticulum calcium ATPase

PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1α

“…To measure PP1 activity, the ProFluor Ser/Thr Phosphatase Assay kit (Promega) was used as described previously (54). Okadaic acid and tautomycetin were from Applichem and Tocris, respectively.…”

Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells

“…However, its activity is markedly inhibited following phosphorylation of Ser-21 of GSK-3α and Ser-9 of GSK-3β by AKT and RPS6KA3. 12,13 We found GSK-3β and GSK-3α downregulated by phosphorylated Ser-9 and Ser-21 early in Dicer-competent and late in Dicer1-disrupted cells. Upon phosphorylation by GSK-3, the affinity of transcription factor JUN to DNA as well as the gene-regulatory activity of the calcineurin/NFAT system is severely impeded.…”

GSK-3 protein and the heart: friend or foe?

“…In addition, the non-specific GSK-3 inhibitor LiCl, completely reversed the inhibition of SERCA2 mRNA expression. To underscore these results, King et al, (55) using the protein phosphatase-1/inhibitor-2 complex to regulate the phosphorylation state of GSK-3, demonstrated increased SERCA2 expression.…”